Search for: "Gilead Sciences Limited"
Results 61 - 80
of 84
Sort by Relevance
|
Sort by Date
22 Apr 2014, 11:51 am
By Dennis Crouch Gilead Sciences v. [read post]
1 Apr 2014, 11:27 am
Gilead Sciences, Inc., 2014 NCBC 10 is a procedural conundrum wrapped up in arbitration issues. [read post]
7 Jul 2013, 9:33 am
Usha Rao 2100/DEL/2007 GILEAD SCIENCES,INC. 25(1), Refused Hardev Karar 1135/DEL/2007 GILEAD SCIENCES, INC. 25(1), Refused Hardev Karar 3221/DELNP/2006 IBM Refused M Ravishankar 280/MUM/2005 TATA CHEMICALS LIMITED Refused N. [read post]
30 Jun 2013, 1:12 pm
MPP succeeds in licensing key HIV medicinesGopika reported a recent success recorded by the Medicines Patent Pool (MPP) in assisting patent licensing negotiations between Gilead Sciences and Karnataka-based Shilpa Medicare. [read post]
3 Mar 2013, 12:06 pm
Patil 1383/MUMNP/2007 GILEAD SCIENCES INC. [read post]
7 Feb 2013, 9:00 am
The SEV calls for a precautionary, science-based approach to decision-making. [read post]
14 Jun 2012, 8:47 am
Gregg Alton, Executive Vice President, Corporate and Medical Affairs, Gilead Sciences. [read post]
4 Apr 2012, 4:20 am
[Link] Gilead Sciences is searching for patent litigation counsel with a BS in life sciences and 5-8 years of experience to work at their Foster City, CA office. [read post]
19 Oct 2011, 3:30 am
(IPBiz) US: Patent protection for the BRCA1 gene and genetic diagnostic methods in the USA: AMP v USPTO (JIPLP) US: Marking with an unenforceable patent does not create intent to deceive: Hollander v Hospira (Chicago Intellectual Property Law Blog) US: Regenerative Sciences lawsuit update and FDA’s attempt to broaden the definition of “interstate commerce”: USA v Regenerative Sciences (FDA Law Blog) Products Embeda (Morphine, Naltrexone) – US: Pfizer,… [read post]
7 Sep 2011, 4:22 am
General 10 considerations in a life sciences license (Richard C. [read post]
16 Mar 2011, 3:50 am
Abbott: Federal Circuit struggles to articulate a coherent standard for compliance with the Lilly written description requirement (Holman’s Biotech IP Blog) Lexapro (Escitalopram) – US: CAFC affirms obviousness of Infosint’s patent claims (IPBiz) Lotronex (Alosetron) – US: Prometheus files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Pravastatine – Belgium/France: Post-expiry saisie-contrefaçon: Belgium and France… [read post]
22 Oct 2010, 5:39 pm
" In re Gilead Sciences Securities Litig. (9th Cir. 2008).Misrepresentation involves the logically difficult task of proving a negative. [read post]
30 Aug 2010, 1:12 pm
What we have, according to Osborn, is "the government's de facto policy of limited rulemaking and broad enforcement. [read post]
23 Mar 2010, 7:22 pm
But I’ve got all this investment in the idea that there’s balm in gilead. [read post]
12 Feb 2010, 6:55 am
“If this science and innovation can’t be patented, it is sending a very strong message about how limited India’s patent protections are,” says Gregg Alton, executive vice-president of corporate and medical affairs at Gilead Sciences. [read post]
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
20 May 2009, 5:18 am
’ (Patent Docs) Atripla/Truvada (Efavirenz, Emtricitabine, Tenofovir) – US: Gilead Sciences files second patent infringement lawsuit against Teva Pharmaceuticals over Emtricitabine, a component of Truvada and Atripla (SmartBrief) (The IP Factor) (GenericsWeb) Champix (Varenicline) – India: Pfizer responds to Dr Reddy’s post-grant opposition to Champix filed at Mumbai Patent Office (GenericsWeb) (Spicy IP) Corpril (Ramipril) –… [read post]
9 Apr 2009, 2:12 pm
Opinion below (5th Circuit) Petition for certiorari Brief in opposition Petitioner's reply brief Brief amicus curiae of former federal and state prosecutors (in support of petitioner) Docket: 08-1021 Title: Gilead Sciences, Inc., et al., v. [read post]
25 Aug 2008, 2:05 am
Gilead Sciences, Inc., No. 06-4290 (July 14, 2008). [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
